Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
Image courtesy of Sirio Pharma
Sirio Pharma (City of Industry, CA) has announced a new range of ready-to-market, organic gummies and softgels, called PureOrganix. The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria. The PureOrganix series target women’s health, metabolic health, and heart health. These include one gummy and softgel with 200 mg and 500 mg of evening primrose oil (EPO), respectively, to support PMS and menopause, a metabolic health gummy with 500 mg of apple cider vinegar, and a heart health gummy with 120 mg of flaxseed oil to support healthy cholesterol.
“We meticulously designed our new organic range so our brand customers could quickly introduce first-in-class products with organic ingredients,” said Sara Lesina, general manager of Sirio Europe & Americas, in a press release. “Thanks to our global R&D team, we have successfully created consumer-friendly dosages for some of the most in-demand botanical ingredients, like EPO and apple cider vinegar. We see a significant opportunity for brands to differentiate with organic nutraceutical gummies and softgels, especially for those that come with proven health benefits and formulary excellence.”
